Fund code: 299

  • NAV $69.32 $0.09 / 0.13%
    03-Dec-2024
  • Inception 05-Jun-1997
  • Benchmark MSCI AC World Health Care Index
  • Aggregate assets
    (all series)
    $273.7M
    30-Nov-2024
  • MER 2.25%
    30-Sep-2024
  • Distributions
  • Morningstar category Sector Equity
  • Also available through Trust US$ and Class CDN$
  • Get Fund Facts

End investment

Annualized return

Choose a chart type (percentage or dollar)
Choose a predefined chart period
to:

Start NAV

$10.0000

End NAV

$10.4031
Choose a predefined chart period
to:

Calendar returns (%) 30-Nov-2024

YTD 2024 2023 2022 2021 2020 2019 2018 2017
Fund 11.33 2.95 -7.74 19.22 9.18 18.30 13.84 10.92

Standard period returns (%) 30-Nov-2024

1 mo 3 mo 6 mo 1 yr 3 yr 5 yr 10 yr Inception
Fund 0.25 -6.95 0.90 13.49 3.86 6.90 8.24 7.37

Why invest in this fund?

  • Offers exposure to dynamic growth opportunities across the global health care sector.
  • Leverages Fidelity’s expertise in managing industry-specific funds.

Risk measures (%) 31-Oct-2024

Fund
Annualized standard deviation 11.94
Beta 1.09
0.92

Risk classification

  1. Low
  2. Low to medium
  3. Medium
  4. Medium to high
  5. High

This fund has a medium volatility rating

Allocation

Asset mix (%)

31-Oct-2024

Country mix (%)

31-Oct-2024

Sector mix (%)

31-Oct-2024
12 months ago Last month Current month
Health Care Equipment & Supplies 19.5 27.0 28.3
Pharma Products 27.5 24.7 26.6
Health Care Providers & Services 21.4 19.5 17.0
Life Sciences Tools & Services 19.6 15.6 14.4
Biotech. 7.4 9.4 11.3

Top ten holdings

  1. UnitedHealth Group
  2. Boston Scientific
  3. Eli Lilly and Company
  4. Novo-Nordisk, Cl. B
  5. Stryker
  6. Danaher
  7. AstraZeneca
  8. Thermo Fisher Scientific
  9. Regeneron Pharmaceuticals
  10. ICON plc
Total number of holdings 46
Top ten holdings aggregate 51.9%
  1. UnitedHealth Group
  2. Novo-Nordisk, Cl. B
  3. Eli Lilly and Company
  4. Boston Scientific
  5. AstraZeneca
  6. Stryker
  7. Thermo Fisher Scientific
  8. ICON plc
  9. Regeneron Pharmaceuticals
  10. Elevance Health
Total number of holdings 44
Top ten holdings aggregate 54.7%
  1. UnitedHealth Group
  2. Novo-Nordisk, Cl. B
  3. Eli Lilly and Company
  4. Thermo Fisher Scientific
  5. Roche Holding
  6. Stryker
  7. ICON plc
  8. Boston Scientific
  9. HCA Healthcare
  10. Regeneron Pharmaceuticals
Total number of holdings 44
Top ten holdings aggregate 49.9%
  1. UnitedHealth Group
  2. Thermo Fisher Scientific
  3. Roche Holding
  4. Novo-Nordisk, Cl. B
  5. Stryker
  6. ICON plc
  7. Eli Lilly and Company
  8. Elevance Health
  9. Boston Scientific
  10. AstraZeneca
Total number of holdings 44
Top ten holdings aggregate 48.5%
View all